TECH EXPERT
Dr Gurvinder Singh

Dr Gurvinder Singh

General Manager & Co-founder

Formugenix Pte Ltd

EXPERTISE:
Healthcare - Product Design & Development, Test & Verification/Clinical Trials, Certification/Regulatory Compliance
Life Sciences - Product Design & Development, Test & Verification/Clinical Trials, Certification/Regulatory Compliance
Show more >
LOCATION:
Singapore

BIOGRAPHY

Dr Singh is a Pharmacy postgraduate with PhD in Cancer Biology. He is an experienced pharma, healthcare and contract research professional with over 17 years in research and development, business development, operations, and general management. He moved to Singapore to set-up and lead the oncology department at Maccine Pte Ltd. The role led him to become Director of Operations with overall operations management responsibilities of 3 different sites. He was also associated with Biopolis Shared Facilities (A*STAR) as Head of Scientific Services and as Program Manager at Singapore Eye Research Institute.

Dr Singh founded an R&D and business consultancy in 2016, World of Pharma Outsourcing. He co-founded a consultancy firm, Formugenix Pte Ltd in 2018 to provide consultancy in the area of formulation and analytical development to pharma, biotech, and personal care industries. He was also associated with Canadian consultancy firm, L2 Consulting.

Dr Singh has a wide range of experiences and provides consultancy and expert services in the areas of pre-clinical, clinical, regulatory outsourcing needs for top pharmaceutical companies, as well as formulation and analytical development and financial services.

PORTFOLIO

R&D and Regulatory Consultancy

Assisted clients from pharmaceutical, biotech and life sciences industries with toxicology studies, IND/NDA enabling studies, formulation development, analytical development and pre-clinical/clinical studies.


Expertise Provided
  • Healthcare - Product Design & Development, Test & Verification/Clinical Trials, Certification/Regulatory Compliance
  • Life Sciences - Product Design & Development, Test & Verification/Clinical Trials, Certification/Regulatory Compliance
Pre-clinical Programme

Propose a pre-clinical programme as part of the development and Investigational New Drug application (IND) of a novel meningioccal vaccine. The programme includes an immunogenicity study as well as toxicity and reactogenicity evaluations. Also provided advice for further pharmacology and toxicity studies that are projected during phases of clinical trials.


Expertise Provided
  • Healthcare - Test & Verification/Clinical Trials, Certification/Regulatory Compliance
  • Life Sciences - Test & Verification/Clinical Trials, Certification/Regulatory Compliance
RELATED TECH EXPERT
Dr Susmita Bandyopadhyay

Chemicals
Healthcare

Dr Gu Keyu

Life Sciences

Dr Ritu Bhalla

Life Sciences

Dr Sun Guang Wen

Life Sciences

Dr Suchitra Derebail

Healthcare
Life Sciences

Dr Gan Eng Seng

Life Sciences

Dr Sharon Lim

Healthcare
Life Sciences

Dr Chiradip Chatterjee

Chemicals
Personal Care

Dr Harmeet Singh

Healthcare
Life Sciences

Dr Tan Shi-Xiong

Healthcare
Life Sciences